Employees: 11-50
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| - | Shanghai Y... | yl-pharma.... | - | - |
| - | Pykus Ther... | pykusthera... | - | - |
| - | Circle Pha... | circlephar... | $117.5M | United Sta... |
| - | CAMP4 Ther... | camp4tx.co... | $175M | United Sta... |
| - | Obsidian T... | obsidiantx... | $164.54M | United Sta... |
| - | WordPress ... | blueoakpha... | - | - |
| - | APRINOIA T... | aprinoia.c... | $11M | Taiwan, Ta... |
| - | Morphic Th... | morphictx.... | $131.5M | United Sta... |
| - | Tilosthera... | tilosthera... | - | - |
| - | Valitor | valitorbio... | $28M | United Sta... |
Show more
News 21
| Date | Title | Description |
| - | ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as ... | ShangPharma Innovation (SPI) today announced the appointment of Mohamad Moghadam-Tabrizi to the posi... |
| - | Partners HealthCare raises $171 million to invest in early-s... | Boston, Massachusetts., Nov. 8, 2017 – Exclusively dedicated to the development of breakthrough tech... |
| - | ShangPharma Innovation and SRI International Announce Drug D... | Strategic partnership to target Alzheimer’s disease and other neurodegenerative and inflammatory con... |
| - | ShangPharma Innovation and the University of California San ... | — New innovation group and leading medical center partner on novel approach to advance therapies acr... |
| - | BioSpace: ShangPharma Innovation and Icahn School of Medicin... | “ShangPharma Innovation Inc., a global venture capital firm focused on biomedical R&D therapeuti... |
| - | ShangPharma Innovation Appoints Walter H. Moos as CEO | SAN FRANCISCO, April 10, 2017 —ShangPharma Innovation, a newly incorporated division of the ShangPha... |
| - | ShangPharma Innovation and Icahn School of Medicine at Mount... | SOUTH SAN FRANCISCO, California and NEW YORK, Jan. 16, 2017 — ShangPharma Innovation Inc., a global ... |
| - | Outsourcing-Pharma: SRI teams up with ShangPharma to target ... | “ShangPharma Innovation and SRI International are collaborating to develop treatments for neurodegen... |
| - | Endpoints: When VCs hand out mega-rounds to Vir and Gossamer... | “Following a period of unprecedented returns for biopharma investors, flush VCs are sinking bigger a... |
| - | BioWorld: Other news to note | “Shangpharma Innovation Inc., of South San Francisco, inked a multiyear strategic collaboration with... |
Show more
Mentions in press and media 4
| Date | Title | Description | Source |
| 06.11.2019 | Artios Pharma, MD Anderson and ShangPharma Announce In-Licen... | CAMBRIDGE, England and HOUSTON and SOUTH SAN FRANCISCO, Calif., Nov. 6, 2019 — Artios Pharma Limited... | svhealthin... |
| 19.03.2018 | ShangPharma boosts Bay Area reach for early-stage research | Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast ... | fiercebiot... |
| 19.03.2018 | ShangPharma boosts Bay Area reach for early-stage research | Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast ... | fiercebiot... |
| 27.10.2017 | ShangPharma Innovation Appoints Two Executives-In-Residence | ShangPharma Innovation Inc., a South San Francisco, CA-based global venture capital firm and innovat... | finsmes.co... |